Zsofia D. Drobni, MD, PhD (@zsofidrobni) 's Twitter Profile
Zsofia D. Drobni, MD, PhD

@zsofidrobni

Cardiology fellow @semmelweishu | Alumni research fellow @MassGeneral @CIRC_MGH | #CVImaging & #Cardiooncology

ID: 506208705

calendar_today27-02-2012 18:22:43

200 Tweet

440 Followers

930 Following

International Cardio-Oncology Society (@icosociety) 's Twitter Profile Photo

Excellent discussion case on 5-FU toxicity/capecitabine - by Dr Nohria, B. Dhesy-Thind - the case is not clear yet.. tune in to hear till the end of pre-conference of #GCOS22 dineshpmcc

Zsofia D. Drobni, MD, PhD (@zsofidrobni) 's Twitter Profile Photo

Great summary of the #DISCHARGE trial results by @ProfDewey at the Hungarian CV Imaging Meeting! 💁🏻‍♀️ Stay tuned for the results from the next analysis! 👱‍♂️🫀👩‍🦳 Pál Maurovich-Horvat Team Dewey Semmelweis University #CardiacCT #chestpain

Great summary of the #DISCHARGE trial results by @ProfDewey at the Hungarian CV Imaging Meeting! 💁🏻‍♀️ Stay tuned for the results from the next analysis! 👱‍♂️🫀👩‍🦳 <a href="/PalMaurovich/">Pál Maurovich-Horvat</a> <a href="/team_dewey/">Team Dewey</a> <a href="/semmelweishu/">Semmelweis University</a> #CardiacCT #chestpain
Stephen V Liu, MD (@stephenvliu) 's Twitter Profile Photo

Be sure to read the latest ESMO Clinical Practice Guideline Annals of Oncology for multi-disciplinary guidance on toxicities from cancer immunotherapy. ESMO - Eur. Oncology annalsofoncology.org/article/S0923-…

Tomas G. Neilan, MD, MPH (@tomasneilan) 's Twitter Profile Photo

Sodium-glucose cotransporter-2 inhibitors and heart failure and mortality in patients with cancer heart.bmj.com/content/early/… In a large mostly non-anthracycline cancer population, SGLT2i use was associated with lower incident HF and prolonged overall survival

Tomas G. Neilan, MD, MPH (@tomasneilan) 's Twitter Profile Photo

From @jaccjournals, over 30% of cancer patients are eligible for an ICI. A review on the potential for ICI related atherosclerosis - JACC: CardioOncology led by the amazing Giselle A. Suero Abreu, MD PhD from Mass General Heart and MGH Cardiology Fellows rb.gy/sgywti

Jacobi Internal Medicine Chiefs (@jmcchiefs) 's Twitter Profile Photo

Ibolya is a fantastic medical educator and recipient of Albert Einstein College of Medicine - Official Davidoff Society Teaching star award. 🌟 She is a team player, and an incredible source of support to her co-residents and interns. Thank you Ibi!! #JacobiStrong #MedTwitter #IMG #CardioTwitter

Ibolya is a fantastic medical educator and recipient of <a href="/EinsteinMed/">Albert Einstein College of Medicine - Official</a> Davidoff Society Teaching star award. 🌟 

She is a team player, and an incredible source of support to her co-residents and interns. Thank you Ibi!! #JacobiStrong #MedTwitter #IMG #CardioTwitter
Pál Maurovich-Horvat (@palmaurovich) 's Twitter Profile Photo

Should post STEMI PCI pathway include routine #FFRCT for assessing flow impairment of non culprit lesions? 🫀Thought provoking #XPECTMI study suggests #YesCCT at index event can predict future invasive FFR‼️ Fantastic work by Semmelweis University researchers! Congrats!

Semmelweis University (@semmelweishu) 's Twitter Profile Photo

Dr. Scott David Solomon, the world-renowned cardiologist of Harvard Medical School received the university’s most prestigious international scientific recognition, the Semmelweis Budapest Award. Heartfelt congratulations to Professor Solomon! Read more: semmelweis.hu/english/2023/0…

Dr. Scott David Solomon, the world-renowned cardiologist of Harvard Medical School received the university’s most prestigious international scientific recognition, the Semmelweis Budapest Award. Heartfelt congratulations to Professor Solomon!
Read more:
semmelweis.hu/english/2023/0…
JAMA (@jama_current) 's Twitter Profile Photo

Among study participants with lymphoma who were being treated with anthracyclines, prophylactic use of atorvastatin over 12 months was associated with a lower rate of cardiac systolic dysfunction. ja.ma/3QtDb8M

Among study participants with lymphoma who were being treated with anthracyclines, prophylactic use of atorvastatin over 12 months was associated with a lower rate of cardiac systolic dysfunction. ja.ma/3QtDb8M